MRL828
MRL828 is a compound that combines a Tau pathology-binding ligand with a guanine group modified by ATTEC technology, allowing it to selectively target aggregated tau proteins for clearance via the autophagy-lysosome pathway (ALP) . MRL828 reduces intracellular Tau aggregates and facilitates the secretion of Tau.
Product Specifications
Field of Research
Cell Biology, Pharmacology & Drug Discovery, Signal Transduction
Molecular Formula
C46H51FN14O5S
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
245169-APC 100 µL
CYP51A1 (Cytochrome P450, Family 51, Subfamily A, Polypeptide 1, CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1) (APC)
Sign In for Pricing
View Details 